Another 4.4 million Americans filed for unemployment benefits last week, as the economy continues to hemorrhage jobs. Dan digs in with New York Times econ and tax policy reporter Jim Tankersley.

Go deeper

Updated 14 hours ago - Health

World coronavirus updates

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

The number of COVID-19 cases surpassed 20 million worldwide on Monday evening, Johns Hopkins data shows.

The big picture: World Health Organization chief Tedros Adhanom Ghebreyesus told a virtual press conference as the world approached the milestone that 750,000 deaths were set to be recorded this week. "Every life lost matters," he said. "But I want to be clear: there are green shoots of hope and... it's never too late to turn the outbreak around."

Biden campaign vows virus focus

Joe Biden puts on a mask after a campaign event in Wilmington, Del., on Tuesday. Photo: Andrew Caballero-Reynolds/AFP via Getty Images

Joe Biden's campaign contends that President Trump's talk of delaying November's election is an effort to distract, and vows to be what a Biden aide called "laser-focused" on Trump's pandemic response.

Why it matters: After aides convinced the president that the issue was hurting him badly in the polls, Trump has tried for the past two weeks to show renewed focus on the coronavirus, including the restoration of his briefings.

Jul 31, 2020 - Health

GlaxoSmithKline and Sanofi nab $2.1 billion federal vaccine deal

A Sanofi vaccine manufacturing plant in France. Photo: Joel Saget/AFP via Getty Images

The Trump administration is paying GlaxoSmithKline and Sanofi $2.1 billion to help the companies get their coronavirus vaccine through clinical trials, cover some manufacturing costs and purchase an initial batch of 100 million doses.

The big picture: The deal, which also includes the option of buying another 500 million doses, is part of the federal government's plan to accelerate the development of as many promising vaccine candidates as possible.